HEARTCARE-B6609.HKValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Fair Value Range” zone.
As of Oct 16, 2026, HEARTCARE-B (6609.HK) trades at a P/E of 19.50x, P/B of 1.49x, P/S of 3.55x, and a dividend yield of 0.00%.
Longitudinal percentile comparison: P/E sits at the 26th percentile over the trailing 10Y window (vs. 26th percentile over 3Y); P/B sits at the 75th percentile over the trailing 10Y window (vs. 73rd percentile over 3Y); P/S sits at the 23rd percentile over the trailing 10Y window (vs. 40th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 60th percentile within its industry and the 72nd percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 1.35%, ranking at the 81st percentile over the trailing 20Y window.
The P/E and P/B percentiles diverge here, differing by 48.7 points — relying on either metric alone could be misleading. Relative to industry peers, its P/E shows a deeper discount than it does against the broader market. Shareholder returns here lean heavily on buybacks rather than cash dividends. HEARTCARE-B operates in the Other Pharmaceuticals and Medical Services sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: HKG: 6609 · SEHK: 6609 · 6609
Want the full picture on whether HEARTCARE-B (6609.HK) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 19.50 | ||||||
| P/B (MRQ) | 1.49 | ||||||
| P/S (TTM) | 3.55 | ||||||
| Dividend Yield | 0.00% | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback + Div Yield | 1.35% |